Related Experiment Video

Updated: Jun 19, 2026

Use of Cerebral Open-Flow Microperfusion for the Longitudinal Collection of Interstitial Fluid in an Animal Model of Glioblastoma
08:50

Use of Cerebral Open-Flow Microperfusion for the Longitudinal Collection of Interstitial Fluid in an Animal Model of Glioblastoma

Published on: December 23, 2025

Ifosfamide encephalopathy and use of methylene blue. A case report of different sequential neurotoxicity

Petros Giovanis1, Antonella Garna, Marilisa Marcante

  • 1Operative Unit of Medical Oncology, City Hospital of Belluno, Belluno, Italy. petros.giovanis@ulss.belluno.it

Tumori
|October 28, 2009
PubMed

Insights

Ifosfamide chemotherapy can cause neurotoxicity, leading to encephalopathy. Methylene blue may not prevent subsequent ifosfamide-induced encephalopathy episodes, even with continued treatment.

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Ifosfamide is an alkylating agent used in chemotherapy.
  • Neurotoxicity is a known adverse effect of ifosfamide, ranging from mild to severe.
  • Ifosfamide-induced encephalopathy typically necessitates chemotherapy cessation and supportive care, including methylene blue administration.

Observation:

  • A patient with retroperitoneal sarcoma developed ifosfamide-induced encephalopathy.
  • The patient experienced a different clinical manifestation of encephalopathy upon continued ifosfamide use.
  • Methylene blue was administered, yet a second encephalopathy episode occurred.

Findings:

  • The efficacy of methylene blue in preventing recurrent ifosfamide-induced encephalopathy during continued chemotherapy is uncertain.
  • This case highlights a potential limitation of methylene blue in managing recurrent neurotoxicity from ifosfamide.
  • A different clinical presentation of ifosfamide neurotoxicity was observed despite prophylactic measures.

Implications:

  • Further research is needed to understand the mechanisms of ifosfamide neurotoxicity and the role of methylene blue.
  • Clinical management strategies for ifosfamide-induced encephalopathy may require re-evaluation.
  • This case underscores the importance of vigilant monitoring for neurotoxicity in patients receiving ifosfamide chemotherapy.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...